Aurora Technologies will begin routinely upgrading its installed base of about 20 dedicated breast MR scanners with an acquisition capability that boosts signal-to-noise by 300%, according to the company. The upgrade, called spiral RODEO (Rotating Delivery of Excitation Off-resonance), was commercially launched at the RSNA meeting.
Aurora Technologies will begin routinely upgrading its installed base of about 20 dedicated breast MR scanners with an acquisition capability that boosts signal-to-noise by 300%, according to the company. The upgrade, called spiral RODEO (Rotating Delivery of Excitation Off-resonance), was commercially launched at the RSNA meeting.
Rather than acquiring data line-by-line, as happens in a conventional fat saturation 3D Fourier transformation, the new approach acquires data from the center of the field-of-view outward in a spiral pattern.
"With spiral RODEO, we are acquiring data 46% of the time, compared to a typical fat-sat acquisition, which does so about 9% of the time," said Dr. Steven Harms, medical director at Aurora.
Current users of the 1.5T Aurora system will get the upgrade first. Facilities that order the breast MR system will receive spiral RODEO automatically, according to Debbie Thomas, vice president of marketing for Aurora.
"Our goal is to have all existing Aurora users upgraded starting right after the RSNA meeting and going into December and next year," she said. "Then we'll continue rolling it out for new orders. The earliest of these, if someone orders today, would be February."
Spiral RODEO was cleared by the FDA almost a year ago and shown as a work-in-progress at the 2005 RSNA meeting. It entered clinical testing in June 2006 at the Breast Center of Northwest Arkansas in Fayetteville, a women's health center operated by Harms, who keeps one foot on the clinical side and the other on the corporate. Harms developed RODEO several years ago, while serving as the director of imaging research at the University of Arkansas in Little Rock.
When applied after contrast injection, this proprietary pulse sequence reduces signal from normal ductal tissue and, thereby avoids false-positive enhancement from benign lesions and dense fibroglandular tissue, according to Harms. The spiral version improves signal-to-noise by a factor of three, he said. This translates into dramatically improved acquisitions: 160 slices with images at 512 x 512 pixels.
Spiral RODEO is a proprietary capability of Aurora. The company's 1.5T scanner was specially designed with oscillating gradients to support this pulse sequence.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.